Repligen | RGEN - Pre Tax Profit

Repligen reported $45.73M in Pre-Tax Profit for its fourth fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview
Pre Tax Profit Change
Agilent A:US USD 471M 60M
Align Technology ALGN:US USD 115.32M 7.32M
Biomarin Pharmaceutical BMRN:US USD -17558000 15.65M
Bruker BRKR:US USD 138.9M 2.4M
Catalent CTLT:US USD 167M 111M
Charles River Laboratories CRL:US USD 190.21M 15.27M
Dentsply International XRAY:US USD 123M 1000K
Exact Sciences EXAS:US USD -129927000 21.95M
Fluidigm FLDM:US USD -20775000 9.36M
Myriad Genetics MYGN:US USD -13800000 6M
Nanostring Technologies NSTG:US USD -44119000 7.49M
Orasure Technologies OSUR:US USD 15.4M 11.26M
Pacific Biosciences Of California PACB:US USD -84384000 7.41M
Patterson Companies PDCO:US USD 78.68M 835K
Peregrine Pharmaceuticals PPHM:US USD 2.53M 5.77M
Pfizer PFE:US USD 7.38B 3.3B
Repligen RGEN:US USD 45.73M 7.94M
Thermo Fisher Scientific TMO:US USD 2.43B 1.25B